Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
Recombinant DNA + Adenovirus Vaccine for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Seattle, Washington
This trial is testing a new vaccine for early stage non-small cell lung cancer. The vaccine consists of two doses of recombinant DNA, followed by two doses of recombinant adenovirus. The trial will evaluate the safety and effectiveness of the vaccine.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.